Capacidad de diagnóstico de sarcopenia con el cuestionario SARC-F y predicción con el ISHII Score en mujeres posmenopáusicas.

Abstract

Sarcopenia is a geriatric syndrome characterized by age-related loss of skeletal muscle mass, strength and physical performance (1); with an increased risk of adverse clinical outcomes, poor quality of life and death (2-3). Sarcopenia is a prevalent geriatric syndrome in the last decades of life, especially in institutionalized and hospitalized elderly (4). Using the criteria of the European Working Group on Sarcopenia in Older People Revision (EWGSOP2), the prevalence was approximately 1-29% in older adults living in communities, 14-33% in older adults living in long-term care and 10 -25.3% in hospitalized elderly (5.6). Sarcopenia screening using the SARC-F questionnaire and the Ishii score; Sarcopenia diagnostic criteria; Measurement of muscle strength; Measurement of muscle mass; Measurement of physical performance; Statistic analysis. A total of 186 postmenopausal women were included in this study, 101 of them were diagnosed with sarcopenia according to the criteria recommended by EWGSOP2, 77 and 118 were classified as sarcopenic according to the SARC-F and the Ishi score, respectively. Significant differences were found between the sarcopenic and non-sarcopenic groups. In conclusion, the Ishii presented a better sensitivity and specificity score in relation to the SARC-F for the diagnosis of sarcopenia in post-menopausal women from marginal urban communities of the city of Guayaquil.